Yuwei Yan

Yuwei Yan

Auto-generated profile, based on publicly available information

Yuwei Yan

Jiangxi University of Chinese Medicine, Nanchang, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Cancer Control
Verified
Journal Article
Open access
CZChen Zhong
Chen Zhong
GWGuojuan Wang
Guojuan Wang
MGMin Guo
Min Guo
NZNaicheng Zhu
Naicheng Zhu
XCXiudan Chen
Xiudan Chen
WYWenyan Yu
Wenyan Yu
Background: Colorectal cancer is a major cause of mortality among the prevalent malignant tumors of the gastrointestinal tract. Although chemotherapy is a standard treatment for colorectal cancer, its efficacy is limited by chemoresistance. Recent studies have investigated targeting tumor stem cells as a potential new therapeutic approach for addressing chemoresistance in colorectal cancer. Colorectal cancer frequently relapses, with tumor stem cells often representing one of the leading causes of treatment failure. Purpose: Understanding drug resistance in colorectal cancer stem cells is crucial for improving treatment outcomes. By focusing on developing targeted therapies that specifically address drug resistance in colorectal cancer stem cells, there is potential to make significant advancements in the treatment of colorectal cancer.This approach may lead to more effective and lasting outcomes in patients battling colorectal cancer. Research Design: In this review, a comprehensive overview of recent research on colorectal cancer stem cell treatment resistance is presented.Results: Elucidating the key underlying mechanisms. This review also highlights the potential benefits of targeted therapies in overcoming colorectal cancer resistance to treatment. Conclusions: CCSCs are key players in drug resistance of CRC, indicating their potential as targets for effective therapy. Elucidating their role in this process could aid in discovering tailored treatment strategies.The significance of signaling pathways, TME, and miRNA in regulating drug resistance in CCSCs is been highlighted.

1 April 2022 in Journal of Alloys and Compounds
Verified
Journal Article
Closed access
YYYuwei Yan
Yuwei Yan
桂荣 李桂荣 李
桂荣 李
WRWenxiang Ren
Wenxiang Ren
HWHongming Wang
Hongming Wang
LGLipeng Gao
Lipeng Gao